Cargando…
Preoperative serum immunoglobulin G and A antibodies to Porphyromonas gingivalis are potential serum biomarkers for the diagnosis and prognosis of esophageal squamous cell carcinoma
BACKGROUND: The key-stone-pathogen, Porphyromonas gingivalis associates not only with periodontal diseases but with a variety of other chronic diseases such as cancer. We previously reported an association between the presence of Porphyromonas gingivalis in esophageal squamous cell carcinoma (ESCC)...
Autores principales: | Gao, She-Gan, Yang, Jun-Qiang, Ma, Zhi-Kun, Yuan, Xiang, Zhao, Chen, Wang, Guang-Chao, Wei, Hua, Feng, Xiao-Shan, Qi, Yi-Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5753462/ https://www.ncbi.nlm.nih.gov/pubmed/29298684 http://dx.doi.org/10.1186/s12885-017-3905-1 |
Ejemplares similares
-
Association of serum immunoglobulin-G to Porphyromonas gingivalis with acute cerebral infarction in the Chinese population
por: Zhang, Zheng, et al.
Publicado: (2015) -
Porphyromonas gingivalis predicts local recurrence after endoscopic submucosal dissection of early esophageal squamous cell carcinoma or precancerous lesion
por: Gao, She-Gan, et al.
Publicado: (2023) -
Oral Administration of Porphyromonas gingivalis Alters the Gut Microbiome and Serum Metabolome
por: Kato, Tamotsu, et al.
Publicado: (2018) -
Porphyromonas gingivalis promotes progression of esophageal squamous cell cancer via TGFβ-dependent Smad/YAP/TAZ signaling
por: Qi, Yi-Jun, et al.
Publicado: (2020) -
Immunoglobulin G antibodies against Porphyromonas gingivalis or Aggregatibacter actinomycetemcomitans in cardiovascular disease and periodontitis
por: Damgaard, Christian, et al.
Publicado: (2017)